0001366340-17-000100.txt : 20171214
0001366340-17-000100.hdr.sgml : 20171214
20171214171927
ACCESSION NUMBER: 0001366340-17-000100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171212
FILED AS OF DATE: 20171214
DATE AS OF CHANGE: 20171214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Noonan Michael David
CENTRAL INDEX KEY: 0001332664
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33304
FILM NUMBER: 171256964
MAIL ADDRESS:
STREET 1: 2000 UNIVERSITY AVE, SUITE 600
CITY: PALO ALTO
STATE: CA
ZIP: 94303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FINJAN HOLDINGS, INC.
CENTRAL INDEX KEY: 0001366340
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
IRS NUMBER: 204075963
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 UNIVERSITY AVENUE
STREET 2: SUITE 600
CITY: EAST PALO ALTO
STATE: CA
ZIP: 94303
BUSINESS PHONE: (650) 282-3228
MAIL ADDRESS:
STREET 1: 2000 UNIVERSITY AVENUE
STREET 2: SUITE 600
CITY: EAST PALO ALTO
STATE: CA
ZIP: 94303
FORMER COMPANY:
FORMER CONFORMED NAME: Converted Organics Inc.
DATE OF NAME CHANGE: 20060616
4
1
wf-form4_151328995372229.xml
FORM 4
X0306
4
2017-12-12
0
0001366340
FINJAN HOLDINGS, INC.
FNJN
0001332664
Noonan Michael David
C/O FINJAN HOLDINGS, INC.
2000 UNIVERSITY AVE, SUITE 600
E. PALO ALTO
CA
94303
0
1
0
0
Chief Financial Officer
Common Stock Option (right to buy)
2.25
2017-12-12
4
A
0
50000
0
A
2018-12-12
2027-12-12
Common Stock
50000.0
50000
D
Common Stock Option (right to buy)
2.25
2017-12-12
4
A
0
70000
0
A
2019-12-12
2027-12-12
Common Stock
70000.0
70000
D
Common Stock Option (right to buy)
2.25
2017-12-12
4
A
0
70000
0
A
2020-12-12
2027-12-12
Common Stock
70000.0
70000
D
The option will vest and become exercisable as to 3,333 shares of common stock of Finjan Holdings, Inc. on the first anniversary of the grant date and vest as to 12.5% of the remaining balance of the shares of common stock in equal installments every three calendar months thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on December 12, 2020.
The option will vest and become exercisable as to 33.3333% of the original grant on the second anniversary of the grant date and vest as to 8.3333% of the original grant in equal installments every three calendar months thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on December 12, 2021.
The option will vest and become exercisable as to 33.3333% of the original grant on the third anniversary of the grant date and vest as to 8.3333% of the original grant in equal installments every three calendar months thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on December 12, 2022.
/s/ Michael Noonan
2017-12-14